Communication with Family Members about Positive BRCA1/2 Genetic Test Results in Korean Hereditary Breast Cancer Families |
Kang, Eun-Young
(Department of Surgery, Seoul National University Bundang Hospital)
Park, Sue-K. (Department of Preventive Medicine, Seoul National University College of Medicine) Kim, Ku-Sang (Department of Surgery, Ajou University School of Medicine) Choi, Doo-Ho (Department of Radiation Oncology, Sungkyunkwan University School of Medicine) Nam, Seok-Jin (Department of Surgery, Sungkyunkwan University School of Medicine) Paik, Nam-Sun (Department of Surgery, Ewha Womans' University Medical Center) Lee, Jong-Won (Department of Surgery, Asan Medical Center, College of Medicine, University of Ulsan) Lee, Min-Hyuk (Department of Surgery, Soonchunhyang University Hospital) Kim, Sung-Won (Department of Surgery, Seoul National University Bundang Hospital) |
1 | Wooster R, Weber BL. Breast and ovarian cancer. N Engl J Med 2003;348:2339-47. DOI ScienceOn |
2 | Pasacreta JV. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Cancer Invest 2003;21:588-623. DOI ScienceOn |
3 | van Oostrom I, Meijers-Heijboer H, Lodder LN, Duivenvoorden Duivenvoorden HJ, van Gool AR, Seynaeve C, et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 2003;21:3867-74. |
4 | Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 2008;10:19-32. DOI ScienceOn |
5 | Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72: 1117-30. DOI ScienceOn |
6 | Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-22. |
7 | Hendrick RE, Smith RA, Rutledge JH 3rd, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997:87-92. |
8 | Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:77-84. DOI ScienceOn |
9 | Kim EK, Kim KS, Park SK, Ahn SH, Lee MH, Kim SW, et al. The Korean Hereditary Breast Cancer (KOHBRA) Study: protocol rewiew. J Breast Cancer 2007;10:241-7. DOI ScienceOn |
10 | Kang E, Ahn SH, Noh WC, Noh DY, Jung YS, Kim LS, et al. The KOHBAR Study has changed the practive patterns for managing hereditary breast cancer in Korea. J Breast Cancer 2010;13:351-6. |
11 | Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 2006;24:700-6. DOI ScienceOn |
12 | Green MJ, Peterson SK, Baker MW, Harper GR, Friedman LC, Rubinstein WS, et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. JAMA 2004;292:442-52. DOI ScienceOn |
13 | Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, et al. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 2008;6:333-8. DOI ScienceOn |
14 | Han SA, Park SK, Ahn SH, Son BH, Lee MH, Choi DH, et al. The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report. J Breast Cancer 2009;12:92-9. DOI |
15 | Han SA, Park SK, Ahn SH, Lee MH, Noh DY, Kim LS, et al. The Korean Hereditary Breast Cancer (KOHBRA) Study: Protocols and Interim Report. Clin Oncol 2011;23: 434-41. DOI ScienceOn |
16 | Foster C, Evans DG, Eeles R, Eccles D, Ashley S, Brooks L, et al. Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genet Test 2004;8:23-9. DOI ScienceOn |
17 | McGivern B, Everett J, Yager GG, Baumiller RC, Hafertepen A, Saal HM. Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med 2004;6:503- 9. DOI ScienceOn |
18 | Kim KS, Kim SW, Lee MH, Ahn SH, Park SK, Korean Breast Cancer Society. Practice patterns of surgeons for the management of hereditary breast cancer in Korea. J Breast Cancer 2008;11:95-101. DOI ScienceOn |
19 | Garber JE, Patenaude AF. Ethical, social and counselling issues in hereditary cancer susceptibility. Cancer Surv 1995;25:381-97. |
20 | Julian-Reynier C, Eisinger F, Vennin P, Chabal F, Aurran Y, Nogues C, et al. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet 1996;33:731-6. DOI |
21 | American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21: 2397-406. DOI ScienceOn |
22 | Hughes CH, Lynch H, Durham C, Snyder C, Lemon S, Narod S, et al. Communication of BRCA1/2 test results in hereditary breast cancer families. Cancer Res Ther Control 1999;8:51-9. |
23 | Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A 2003;116A:11-9. DOI |
24 | McGivern B, Everett J, Yoger GG, Baumiller RC, Hafertepen A, Saal HM. Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med 2004;6:503- 9. DOI ScienceOn |